Patents by Inventor Matthias Schwarz

Matthias Schwarz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220238497
    Abstract: An optoelectronic device, in particular an at least semi-transparent pane for example for a vehicle, comprises: a cover layer, a carrier layer, an intermediate layer between the cover layer and the carrier layer, wherein at least one and preferably a plurality of optoelectronic light sources, in particular ?LEDS, is arranged on at least one surface of the intermediate layer and/or is at least partially embedded in the intermediate layer, wherein the intermediate layer is adapted such that light emitted by the optoelectronic light sources at least partially spreads in and along the intermediate layer and exits the intermediate layer within and/or at a pre-set distance to the respective optoelectronic light source in a direction through the cover layer and/or through the carrier layer.
    Type: Application
    Filed: October 29, 2020
    Publication date: July 28, 2022
    Inventors: Michael BRANDL, Andreas DOBNER, Matthias GOLDBACH, Sebastian WITTMANN, Uli HILLER, Markus KLEIN, Thomas SCHWARZ, Andreas WALDSCHIK, Michael WITTMANN, Matthias BRUCKSCHLOEGL, Stefan GROETSCH, Rainer HUBER, Peter BRICK, Ludwig HOFBAUER
  • Publication number: 20220227230
    Abstract: An optoelectronic device comprises a plurality of layer segments, in particular intermediate layer segments, arranged between a cover layer and a carrier layer. At least one optoelectronic component is arranged on at least one of the plurality of layer segments and a first and a second layer segment of the plurality of the layer segments are overlapping each other along a first direction each forming a respective boundary region. The first layer segment comprises at least one first contact pad and the second layer segment comprises at least one second contact pad, wherein the at least one first and second contact pad are arranged in the respective boundary region facing each other and being mechanically and electrically connected. The at least one first and second contact pad each comprises a plurality of nanowires which are at least partially made of conductive material such as for example copper, gold, or nickel.
    Type: Application
    Filed: October 29, 2020
    Publication date: July 21, 2022
    Inventors: Matthias GOLDBACH, Stefan GROETSCH, Ludwig HOFBAUER, Sebastian WITTMANN, Robert REGENSBURGER, Thomas SCHWARZ, Michael BRANDL, Andreas DOBNER, Sebastian STIGLER
  • Patent number: 11260375
    Abstract: The present invention relates to a process for preparing 1,4-butanediol (BDO) by hydrogenating 2-butyne-1,4-diol (BYD) or 4-hydroxybutanal (4-HBA) in the presence of a catalyst of the Raney type having a porous foam structure, wherein the macroscopic pores have sizes in the range of 100 to 5000 ?m, and a bulk density of up to 0.8 kg/L.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: March 1, 2022
    Assignee: Evonik Operations GmbH
    Inventors: Monika Berweiler, Markus Göttlinger, Meike Roos, Matthias Schwarz, René Poss
  • Publication number: 20220050587
    Abstract: A method for traffic monitoring for a monitoring location. The method has a step of outputting a display signal to a user interface. The display signal displays at least one image symbol, relating to at least one configurable parameter of the traffic monitoring, in a combined overview for the monitoring location via the user interface. The at least one image symbol can be influenced by gestural interaction with a user in order to configure the at least one configurable parameter. The method also includes reading in a user input signal from the user interface. The user input signal represents an input by the user, made by gestural interaction with the at least one image symbol and recognized by gesture recognition, to configure the at least one parameter. The method configures the at least one configurable parameter depending on the user input signal in order to set up traffic monitoring.
    Type: Application
    Filed: December 11, 2019
    Publication date: February 17, 2022
    Applicant: JENOPTIK Robot GmbH
    Inventors: Beate GIERSIEPEN, Matthias SCHWARZ, Rainer DORAU, Stefan KIENITZ
  • Publication number: 20210323935
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Application
    Filed: December 4, 2020
    Publication date: October 21, 2021
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL
  • Patent number: 11028054
    Abstract: The present invention provides 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors, in which R1 to R3 and ‘m’ have the meanings given in the specification, and pharmaceutically acceptable salts or stereoisomer thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting DHODH. The present invention also provides methods for synthesizing 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives of formula (I). The present invention also provides pharmaceutical formulations comprising at least one of the DHODH inhibitor compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: June 8, 2021
    Assignee: Merck Patent GmbH
    Inventors: Siva Sanjeeva Rao Thunuguntla, Subramanya Hosahalli, Sunil Kumar Panigrahi, Matthias Schwarz, Michael Arit
  • Publication number: 20200155515
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as preterm labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Application
    Filed: January 27, 2020
    Publication date: May 21, 2020
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL, Ernest LOUMAYE, Oliver POHL, Jean-Pierre GOTTELAND
  • Publication number: 20200140395
    Abstract: The present invention provides 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives as dihydroorotate oxygenase inhibitor compounds of formula (I), which may be therapeutically useful as DHODH inhibitors, in which R1 to R3 and ‘m’ have the meanings given in the specification, and pharmaceutically acceptable salts or stereoisomer thereof that are useful in the treatment and prevention in diseases or disorder, in particular their use in diseases or disorder where there is an advantage in inhibiting DHODH. The present invention also provides methods for synthesizing 1, 4, 6-trisubstituted-2-alkyl-1H-benzo[d]imidazole derivatives of formula (I). The present invention also provides pharmaceutical formulations comprising at least one of the DHODH inhibitor compound of formula (I) together with a pharmaceutically acceptable carrier, diluent or excipient.
    Type: Application
    Filed: February 23, 2018
    Publication date: May 7, 2020
    Inventors: Siva Sanjeeva Rao Thunuguntla, Subramanya Hosahalli, Sunil Kumar Panigrahi, Matthias Schwarz, Michael Arlt
  • Patent number: 10555934
    Abstract: The invention provides pharmaceutical compositions comprising a compound of formula (I) or (II) and an additional therapeutic agent Also provided is the HCI salt and crystalline form of the compound of formula (I). The compounds inhibit the prostaglandin F receptor (PGF2alpha) and thus useful in the treatment of disorders such as preterm labor at the early gestational stage.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: February 11, 2020
    Assignee: ObsEva S.A.
    Inventors: Patrick Naxos Page, Matthias Schwarz, Catherine Jorand-Lebrun, Anna Quattropani, Vincent Pomel, Ernest Loumaye, Oliver Pohl, Jean-Pierre Gotteland
  • Publication number: 20190232256
    Abstract: The present invention relates to a process for preparing 1,4-butanediol (BDO) by hydrogenating 2-butyne-1,4-diol (BYD) or 4-hydroxybutanal (4-HBA) in the presence of a catalyst of the Raney type having a porous foam structure, wherein the macroscopic pores have sizes in the range of 100 to 5000 ?m, and a bulk density of up to 0.8 kg/L.
    Type: Application
    Filed: September 27, 2017
    Publication date: August 1, 2019
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Monika BERWEILER, Markus GÖTTLINGER, Meike ROOS, Matthias SCHWARZ, René POSS
  • Patent number: 10366852
    Abstract: A power relay for a vehicle is disclosed. The power relay has a housing formed by a connector base and a housing can set thereon, two connection bolts being inserted into the connector base for contacting a load circuit. The power relay further has a coil subassembly arranged in the housing and containing a solenoid coil and an armature. The armature is coupled by a force-transmission member to a contact bridge and can shift in the housing, under the effect of a magnetic field generated by the solenoid coil, in such a way that the contact bridge can be reversibly moved between a closing position, in which the contact bridge bridges the connection bolts in an electro conducting manner, and an opening position, in which the contact bridge is not in contact with the connection bolts. The housing can is configured as an injection-molded component made of plastic.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: July 30, 2019
    Assignee: Ellenberger & Poensgen GmbH
    Inventors: Markus Birner, Manuel Engewald, Ricardo Pimenta, Helmut Kraus, Wolfgang Weiss, Matthias Schwarz, Sebastian Rothmayr, Thomas Singer
  • Publication number: 20190194151
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 27, 2019
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL
  • Patent number: 10259795
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: April 16, 2019
    Assignee: Merck Serono S.A.
    Inventors: Patrick Naxos Page, Matthias Schwarz, Catherine Jorand-Lebrun, Anna Quattropani, Vincent Pomel
  • Patent number: 10249462
    Abstract: A power relay for a vehicle, in particular a utility vehicle, is disclosed. The power relay contains a housing formed by a connecting base and a housing pot that is placed on the connecting base. Accordingly, two connecting bolts for establishing contact with an on-load circuit are formed by standard screws.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: April 2, 2019
    Assignee: Ellenberger & Poensgen GmbH
    Inventors: Markus Birner, Manuel Engewald, Ricardo Pimenta, Helmut Kraus, Wolfgang Weiss, Matthias Schwarz, Sebastian Rothmayr, Thomas Singer
  • Publication number: 20190000812
    Abstract: The invention provides pharmaceutical compositions comprising a compound of formula (I) or (II) and an additional therapeutic agent Also provided is the HCI salt and crystalline form of the compound of formula (I). The compounds inhibit the prostaglandin F receptor (PGF2alpha) and thus useful in the treatment of disorders such as preterm labor at the early gestational stage.
    Type: Application
    Filed: January 4, 2017
    Publication date: January 3, 2019
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL, Ernest LOUMAYE, Oliver POHL, Jean-Pierre GOTTELAND
  • Patent number: 10070514
    Abstract: A high current switch, in particular for a motor vehicle, having a first bus bar, a second bus bar in addition to a first semi-conductor switch that has a control connection and a first transmission connection as well as a second transmission connection. The first transmission connection is placed in direct contact with the first bus bar and the second transmission connection is placed in direct electric contact with the second bus bar.
    Type: Grant
    Filed: October 31, 2016
    Date of Patent: September 4, 2018
    Assignee: ELLENBERGER & POENSGEN GMBH
    Inventors: Wolfgang Ullermann, Peter Meckler, Manuel Engewald, Matthias Schwarz, Ewald Schneider, Markus Miklis
  • Publication number: 20180201591
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorphs thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Application
    Filed: October 10, 2017
    Publication date: July 19, 2018
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL
  • Patent number: 9834528
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: December 5, 2017
    Assignee: Merck Serono S.A.
    Inventors: Patrick Naxos Page, Matthias Schwarz, Catherine Jorand-Lebrun, Anna Quattropani, Vincent Pomel
  • Patent number: 9727044
    Abstract: A method for supporting a configuration of an interface is provided, wherein the configuration environment has an overview region that has several subregions. At least one item of information concerning a part of the configuration is displayed in each subregion. For each subregion, an item of information concerning the part of the configuration associated with the subregion is displayed. In the case of a warning and/or error message, a configuration option is displayed so as to be selectable, via which the warning/error message is resolved. The selection of the displayed configuration option causes a functionality to be started via which the displayed configuration option is made possible. In the case of a change in the status of a subregion, the display of the status and/or warning and/or error message and a configuration option derived therefrom in one subregion or several subregions is automatically updated and adapted to the changed status.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: August 8, 2017
    Assignee: dSPACE digital signal processing and control engineering GmbH
    Inventors: Lars Grosse, Martin Kronmueller, Holger Naundorf, Matthias Schwarz
  • Publication number: 20170190677
    Abstract: The invention provides ?-amino esters of a hydroxypropylthiazolidine carboxamide derivative, (2S)-3-([1,1?-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as well as salts and crystal polymorph s thereof, that can be used to inhibit prostaglandin F receptor. The invention further encompasses methods of treating disorders such as pre-term labor at the early gestational stage by the administration of these substances to a patient in need of treatment.
    Type: Application
    Filed: August 8, 2016
    Publication date: July 6, 2017
    Inventors: Patrick Naxos PAGE, Matthias SCHWARZ, Catherine JORAND-LEBRUN, Anna QUATTROPANI, Vincent POMEL